Expand SMMT Menu
SMMT MENU

SMMT Stock Posts


Unusual Option Volume

SMMT Summit Therapeutics24.57+0.15 (+0.6%)

Summit Therapeutics trades 2,588 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
View Details...
Unusual Option Volume

SMMT Summit Therapeutics22.93+1.81 (+8.6%)

Summit Therapeutics trades 1,795 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
View Details...
Unusual Option Volume

SMMT Summit Therapeutics19.59+0.28 (+1.5%)

Summit Therapeutics trades 3,542 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
View Details...
Unusual Option Volume

SMMT Summit Therapeutics18.26+1.28 (+7.5%)

Summit Therapeutics trades 2,339 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
View Details...
Unusual Option Volume

SMMT Summit Therapeutics17.41+0.83 (+5.0%)

Summit Therapeutics trades 1,980 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
View Details...
Unusual Option Volume

SMMT Summit Therapeutics16.82-0.44 (-2.6%)

Summit Therapeutics trades 1,472 contracts. The company has the following event: 2026 European Lung Cancer Congress on Mar 27, 2026. News: Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes